Thus, targeting necroptosis by inhibiting DAMPs like HMGB1 and pro-inflammatory cytokines such as TNF-α may reduce inflammatory mediators, disrupt the inflammatory cycle, and promote pulp tissue repair, offering a promising therapeutic strategy for pulpitis. Here, HMGB1 is linked to pulpitis.